Killing Cancer Cells by Activating the Cellular Intrinsic Nuclear Loss Program
Research Grant Recipient: Wenqian Hu, PhD
Award Value: $250,000
Research Focus: Leukemias
From the Investigator:
A major problem in leukemia treatment is the rise of drug-resistant mutations in the genome of cancer cells, which makes many well-designed cancer drugs ineffective over time. To solve this critical issue, here, we will develop a novel method of killing leukemia cells by inducing them to expel their nuclei.